Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis
Mesenchymal stem cells (MSCs) have great potential to differentiate into various types of cells, including but not limited to, adipocytes, chondrocytes and osteoblasts. In addition to their progenitor characteristics, MSCs hold unique immunomodulatory properties that provide new opportunities in the...
Main Authors: | Madina Sarsenova, Assel Issabekova, Saule Abisheva, Kristina Rutskaya-Moroshan, Vyacheslav Ogay, Arman Saparov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/21/11592 |
Similar Items
-
TNF-α Preconditioning Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in an Experimental Model of Atherosclerosis
by: Aliya Sekenova, et al.
Published: (2023-09-01) -
Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells
by: Madina Sarsenova, et al.
Published: (2022-09-01) -
The Effects of Mesenchymal Stem Cells on the Gene Expression of TGF-beta and IFN-gamma in Patients with Rheumatoid Arthritis
by: Maryam Rahimi Khorashad, et al.
Published: (2023-04-01) -
Human Bone Marrow Mesenchymal Stromal/Stem Cells Regulate the Proinflammatory Response of Monocytes and Myeloid Dendritic Cells from Patients with Rheumatoid Arthritis
by: Paula Laranjeira, et al.
Published: (2022-02-01) -
Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies
by: Yusuke Shimizu, et al.
Published: (2023-07-01)